162 related articles for article (PubMed ID: 33830685)
1. [Multiple myeloma in an elderly patient with history of breast cancer : the value of multidisciplinary oncogeriatric collaboration].
Legros M; Bouillon AS; Janin N; Moonen M; Louviaux I; Salmon JP; Berg N; Servais P
Rev Med Liege; 2021 Apr; 76(4):232-238. PubMed ID: 33830685
[TBL] [Abstract][Full Text] [Related]
2. Transplant-ineligible newly diagnosed multiple myeloma: Current and future approaches to clinical care: A Young International Society of Geriatric Oncology Review Paper.
Grant SJ; Mian HS; Giri S; Boutin M; Dottorini L; Neuendorff NR; Krok-Schoen JL; Nikita N; Rosko AE; Wildes TM; Zweegman S
J Geriatr Oncol; 2021 May; 12(4):499-507. PubMed ID: 33342724
[TBL] [Abstract][Full Text] [Related]
3. Management of Newly Diagnosed Elderly Multiple Myeloma Patients.
Antoine-Pepeljugoski C; Braunstein MJ
Curr Oncol Rep; 2019 May; 21(7):64. PubMed ID: 31127403
[TBL] [Abstract][Full Text] [Related]
4. Management of primary metastatic breast cancer in elderly patients--an international comparison of oncogeriatric versus standard care.
van de Water W; Bastiaannet E; Egan KM; de Craen AJ; Westendorp RG; Balducci L; van de Velde CJ; Liefers GJ; Extermann M
J Geriatr Oncol; 2014 Jul; 5(3):252-9. PubMed ID: 24661770
[TBL] [Abstract][Full Text] [Related]
5. Geriatric assessments and frailty scores in multiple myeloma patients: a needed tool for individualized treatment?
Möller MD; Gengenbach L; Graziani G; Greil C; Wäsch R; Engelhardt M
Curr Opin Oncol; 2021 Nov; 33(6):648-657. PubMed ID: 34534141
[TBL] [Abstract][Full Text] [Related]
6. Low levels of intra-tumoural T cells in breast cancer identify clinically frail patients with shorter disease-specific survival.
Speigl L; Grieb A; Janssen N; Hatse S; Brouwers B; Smeets A; Floris G; Bailur JK; Kenis C; Neven P; Wildiers H; Pawelec G; Shipp C
J Geriatr Oncol; 2018 Nov; 9(6):606-612. PubMed ID: 29685380
[TBL] [Abstract][Full Text] [Related]
7. Structured assessment of frailty in multiple myeloma as a paradigm of individualized treatment algorithms in cancer patients at advanced age.
Engelhardt M; Ihorst G; Duque-Afonso J; Wedding U; Spät-Schwalbe E; Goede V; Kolb G; Stauder R; Wäsch R
Haematologica; 2020 May; 105(5):1183-1188. PubMed ID: 32241848
[No Abstract] [Full Text] [Related]
8. Management of multiple myeloma in older adults: Gaining ground with geriatric assessment.
Wildes TM; Campagnaro E
J Geriatr Oncol; 2017 Jan; 8(1):1-7. PubMed ID: 27118356
[TBL] [Abstract][Full Text] [Related]
9. Multiple myeloma: Current and future management in the aging population.
Fotiou D; Ntanasis-Stathopoulos I; Gavriatopoulou M; Dimopoulos MA
Maturitas; 2020 Aug; 138():8-13. PubMed ID: 32631590
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive geriatric assessment and decision-making in older men with incurable but manageable (chronic) cancer.
Handforth C; Burkinshaw R; Freeman J; Brown JE; Snowden JA; Coleman RE; Greenfield DM
Support Care Cancer; 2019 May; 27(5):1755-1763. PubMed ID: 30143894
[TBL] [Abstract][Full Text] [Related]
11. Treatment of older adult or frail patients with multiple myeloma.
Grant SJ; Freeman CL; Rosko AE
Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):46-54. PubMed ID: 34889397
[TBL] [Abstract][Full Text] [Related]
12. Elderly patients with multiple myeloma: towards a frailty approach?
Zweegman S; Engelhardt M; Larocca A;
Curr Opin Oncol; 2017 Sep; 29(5):315-321. PubMed ID: 28763310
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer and synchronous multiple myeloma as a diagnostic challenge: Case report and review of literature.
Sokołowski M; Mazur G; Butrym A
Curr Probl Cancer; 2018; 42(2):231-234. PubMed ID: 29241676
[TBL] [Abstract][Full Text] [Related]
14. Special considerations for the treatment of multiple myeloma according to advanced age, comorbidities, frailty and organ dysfunction.
Fraz MA; Warraich FH; Warraich SU; Tariq MJ; Warraich Z; Khan AY; Usman M; Ijaz A; Tenneti P; Mushtaq A; Akbar F; Shahid Z; Ali Z; Fazeel HM; Rodriguez C; Nasar A; McBride A; Anwer F
Crit Rev Oncol Hematol; 2019 May; 137():18-26. PubMed ID: 31014512
[TBL] [Abstract][Full Text] [Related]
15. Geriatric Assessment and Frailty Scores Predict Mortality in Myeloma: Systematic Review and Meta-analysis.
Salazar AS; Recinos LM; Mian HS; Stoll C; Simon LE; Sekhon S; Colditz GA; Wildes TM
Clin Lymphoma Myeloma Leuk; 2019 Aug; 19(8):488-496.e6. PubMed ID: 31133527
[TBL] [Abstract][Full Text] [Related]
16. Patient-centered practice in elderly myeloma patients: an overview and consensus from the European Myeloma Network (EMN).
Larocca A; Dold SM; Zweegman S; Terpos E; Wäsch R; D'Agostino M; Scheubeck S; Goldschmidt H; Gay F; Cavo M; Ludwig H; Straka C; Bringhen S; Auner HW; Caers J; Gramatzki M; Offidani M; Dimopoulos MA; Einsele H; Boccadoro M; Sonneveld P; Engelhardt M
Leukemia; 2018 Aug; 32(8):1697-1712. PubMed ID: 29880892
[TBL] [Abstract][Full Text] [Related]
17. Treatment Considerations for Transplant-Ineligible Multiple Myeloma.
Elnair R; Holstein S
Oncology (Williston Park); 2021 Apr; 35(4):170-182. PubMed ID: 33886251
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of multiple myeloma in elderly patients: consensus of the Geriatric Oncology Working Group of the German Society of Hematologic Oncology and the German Society of Geriatrics].
Genvresse I; Wedding U; Bokemeyer C; Späth-Schwalbe E
Onkologie; 2001 Aug; 24(4):386-90. PubMed ID: 11574768
[TBL] [Abstract][Full Text] [Related]
19. How I treat fragile myeloma patients.
Larocca A; Palumbo A
Blood; 2015 Nov; 126(19):2179-85. PubMed ID: 26324701
[TBL] [Abstract][Full Text] [Related]
20. Special Considerations for Supportive Care and Management of Complications in Elderly Patients With Multiple Myeloma.
George LL; Malik MN; Miller EJ; Hicks K; Khanam R; Saterehaseman A; McNichol M; Anwer F
Clin Lymphoma Myeloma Leuk; 2021 Dec; 21(12):812-822. PubMed ID: 34384735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
